University of Alabama at Birmingham School of Medicine is a clinical research site located in Birmingham, Alabama, United States 35249.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Alabama at Birmingham School of Medicine has participated in 16 clinical trials with 4 currently active.
Therapeutic areas: B-cell Non-Hodgkin Lymphoma, Secondary Hemophagocytic Lymphohistiocytosis (sHLH), Candidemia.
Sponsors: Hoffmann-La Roche, Electra Therapeutics Inc., Basilea Pharmaceutica.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Alabama at Birmingham School of Medicine has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Alabama at Birmingham School of Medicine has 16 clinical trials on record, with 4 currently active. Their work covers B-cell Non-Hodgkin Lymphoma, Secondary Hemophagocytic Lymphohistiocytosis (sHLH), Candidemia.
Yes — University of Alabama at Birmingham School of Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.